Appointment booking for Dr. Angelo Argento, MD is currently not available.Dr. Angelo Argento, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Angelo Argento, MD (he/him) is a Internist in Broken Arrow, OK with over 18 years of experience. What is your opinion of Dr. Angelo Argento, MD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 18 Years of Experience
Languages Spoken
English
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Angelo Argento, MD has received over $3,041 which includes payments from the following companies:
$676.39 from Boehringer Ingelheim Pharmaceuticals, Inc.
$441.98 from GlaxoSmithKline, LLC.
$371.84 from AstraZeneca Pharmaceuticals LP
$249.49 from sanofi-aventis U.S. LLC
$201.71 from Takeda Pharmaceuticals America, Inc.
$130.91 from Sunovion Pharmaceuticals Inc.
$122.46 from Novo Nordisk Inc
$121.09 from Stryker Corporation
$97.03 from Ethicon Inc.
$82.09 from Merck Sharp & Dohme Corporation
$68.05 from Pfizer Inc.
$54.99 from Janssen Pharmaceuticals, Inc
$49.48 from Sanofi Pasteur Inc.
$47.20 from Astellas Pharma US Inc
$42.04 from Grifols USA, LLC
$41.65 from Mylan Specialty L.P.
$39.45 from Eisai Inc.
$28.97 from Endo Pharmaceuticals Inc.
$27.83 from Amgen Inc.
$25.14 from bioMerieux
Payments received by Dr. Angelo Argento, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!